| Literature DB >> 35601093 |
Yulu Chen1,2, Kai Song1,2, Xin Chen3, Ye Li1, Ruichen Lv4, Qingwen Zhang5,6, Yujun Cui1, Yujing Bi1, Yanping Han1, Yafang Tan1, Zongmin Du1, Ruifu Yang1,6, Zhizhen Qi5,6, Yajun Song2,3,6.
Abstract
Yersinia pestis is the etiological agent of plague, a deadly infectious disease that has caused millions of deaths throughout history. Obtaining iron from the host is very important for bacterial pathogenicity. Y. pestis possesses many iron uptake systems. Yersiniabactin (Ybt) plays a major role in iron uptake in vivo and in vitro, and in virulence toward mice as well. FyuA, a β-barrel TonB-dependent outer membrane protein, serves as the receptor for Ybt. In this study, we examined the role of the fyuA gene in Y. pestis virulence using different challenging ways and explored the underlying mechanisms. The BALB/c mouse infection assay showed that the virulence of the mutant strains (ΔfyuA and ΔfyuA GCAdel) was lower when compared with that of the wild-type (WT) strain 201. Furthermore, the attenuation of virulence of the mutant strains via subcutaneous and intraperitoneal challenges was far greater than that via intravenous injection. Iron supplementation restored lethality during subcutaneous challenge with the two mutants. Thus, we speculated that the attenuated virulence of the mutant strains toward the mice may be caused by dysfunctional iron uptake. Moreover, ΔfyuA and ΔfyuA GCAdel strains exhibited lower survival rates in murine RAW264.7 macrophages, which might be another reason for the attenuation. We further explored the transcriptomic differences between the WT and mutant strains at different temperatures and found that the expressions of genes related to Ybt synthesis and its regulation were significantly downregulated in the mutant strains. This finding indicates that fyuA might exert a regulatory effect on Ybt. Additionally, the expressions of the components of the type III secretion system were unexpectedly upregulated in the mutants, which is inconsistent with the conventional view that the upregulation of the virulence genes enhances the virulence of the pathogens.Entities:
Keywords: Ybt system; Yersinia pestis; fyuA; iron uptake system; pathogenicity; virulence
Mesh:
Substances:
Year: 2022 PMID: 35601093 PMCID: PMC9114763 DOI: 10.3389/fcimb.2022.874773
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 6.073
Figure 1Growth curves of Y. pestis. Growth curve of WT, ΔfyuA, and ΔfyuA-Comp at 37°C in LB (A), at 26°C in defined TMH with 0.1 mM FeSO4 (C), or at 26°C in deferrated TMH with 10 μM FeCl3 (E). The bacterial growth was monitored by measuring the absorbance at OD620 nm at 2 h intervals. The areas under the growth curve were applied for the statistical analysis of different conditions (B, D, F).
Figure 2Real-time cell analysis assay curves of HeLa cells infected with WT and the two mutants. (A) Normalized CI value curves. The bacteria were added to the cell culture at 10h. (B) Normalized CI values of 14h (4h post infection). (C) Normalized CI values of 18h (8h post infection). (D) Normalized CI values of 21h (11h post infection). **, p < 0.01. ***, p < 0.001.
The ligand binding site of FyuA and FyuAGlndel.
| FyuA | FyuAGlndel | ||||||
|---|---|---|---|---|---|---|---|
| C-score | PDB Hit | Lig Name* | Ligand Binding Site Residues | C-score | PDB Hit | Lig Name | Ligand Binding Site Residues |
| 0.05 | 1ujwA | LIM | 147, 148, 599, 611, 642, 644 | 0.06 | 1ujwA | LIM | 147, 148, 598, 610, 641, 643 |
| 0.05 | 2grxA | FTT | 214, 263, 278, 280, 301, 330 | 0.05 | 3m8bA | C8E | 321, 361, 363, 373, 374, 375, 376 |
| 0.05 | 1nqhA | C8E | 360, 378, 379, 380, 407, 409, 410 | 0.04 | 1NQHA | 1NQHA00 | 60, 61, 62, 63, 64, 65, 67, 76, 77, 78, 79, 80, 229, 230, 231, 232, 287, 297, 544, 545, 623, 624, 625, 632 |
| 0.03 | 2W76B | 2W76B01 | 562, 563, 564, 565, 567, 599, 609, 610, 611, 644, 645, 646 | 0.03 | 1nqgA | C8E | 359, 377, 378, 406, 408, 409, 410 |
| 0.03 | 2GSKA | 2GSKA00 | 60, 61, 62, 63, 64, 65, 67, 76, 77, 78, 79, 80, 229, 230, 231, 232, 287, 289, 296, 298, 545, 546, 624, 625, 626, 633 | 0.03 | 2FCPA | 2FCPA02 | 218, 262, 263, 280, 302, 304, 329 |
*Lig Name is name of possible binding ligand.
Figure 3Y. pestis ΔfyuA and ΔfyuA GCAdel mutants showed virulence attenuation in mice, and iron accelerated the mouse lethality during subcutaneous infection with ΔfyuA and ΔfyuA GCAdel mutants. Each mouse of each group (n = 10) was challenged with 104 CFU of bacteria. (A) Intraperitoneal challenges with WT, ΔfyuA, or ΔfyuA GCAdel. (B) Intravenous challenges with WT, ΔfyuA, or ΔfyuA GCAdel. (C) Subcutaneous challenges with WT, ΔfyuA, ΔfyuA GCAdel, and the complemented strains of the two mutants. (D) The WT, ΔfyuA, and ΔfyuA GCAdel groups were subcutaneously challenged with WT, ΔfyuA, or ΔfyuA GCAdel respectively. The FeCl2 groups were challenged with the mutants and were supplemented with 50 μg of FeCl2 intraperitoneally or subcutaneously plus intraperitoneally. ***, p < 0.001.
Figure 4Comparison of the viabilities of WT and the mutants in blood (A), serum (B) and RAW264.7 cells (C, D). The survival rates of ΔfyuA and ΔfyuA GCAdel mutant strains were lower than that of strain 201 in RAW264.7 cells but showed no significant differences in blood and serum. The experiments were performed three times independently. **, p < 0.01. NS, not significant.
Figure 5Comparative transcriptomics of strain 201 and ΔfyuA GCAdel cultured at 26°C or 37°C. (A) Venn diagrams showing overlapping of the gene expression profiles between different comparison groups. (B) Clustering analysis of differential gene expression between WT and mutant strains. Different colors show different gene expression levels, with high expression being colored red and low expression being colored green. (C) Correlations among the expression levels of 17 genes measured with RNA-seq and qRT-PCR were analyzed using linear regression.
The genes of Ybt system were down-regulated in ΔfyuA GCAdel in comparison with 201-WT.
| gene_id | log2FoldChange 26°C | log2FoldChange 37°C | gene_name | gene_description |
|---|---|---|---|---|
| YP_RS08660 | -2.9 | -2.5 |
| yersiniabactin biosynthesis salicylate synthase YbtS |
| YP_RS08655 | -3.1 | -2.4 |
| yersiniabactin-associated zinc MFS transporter YbtX |
| YP_RS08650 | -2.1 | -2.3 |
| yersiniabactin ABC transporter ATP-binding/permease protein YbtQ |
| YP_RS08645 | -2 | -3.9 |
| yersiniabactin ABC transporter ATP-binding/permease protein YbtP |
| YP_RS08635 | -4.2 | -4 |
| yersiniabactin non-ribosomal peptide synthetase HMWP2 |
| YP_RS08630 | -3 | -2.8 |
| yersiniabactin polyketide synthase HMWP1 |
| YP_RS08625 | -3.5 | -2.9 |
| yersiniabactin biosynthesis oxidoreductase YbtU |
| YP_RS08620 | -4.5 | -3.1 |
| yersiniabactin biosynthesis thioesterase YbtT |
| YP_RS08615 | -2.9 | -2.6 |
| yersiniabactin biosynthesis salycil-AMP ligase YbtE |
| YP_RS08610 | -4.3 | -5 |
| siderophore yersiniabactin receptor FyuA |
The genes of type III secretion system were up-regulated in ΔfyuA GCAdel in comparison with 201-WT at 37°C.
| gene_id | log2FoldChange | gene_name | gene_description |
|---|---|---|---|
| YP_RS21370 | 2.1 |
| YopE transcriptional regulator year |
| YP_RS21365 | 1.5 |
| type III secretion system effector GTPase activator YopE |
| YP_RS21310 | 1.8 |
| T3SS effector cysteine protease YopT |
| YP_RS21305 | 1.4 |
| type III secretion system chaperone SycT |
| YP_RS21285 | 2.1 |
| type III secretion system leucine rich repeat protein |
| YP_RS21270 | 1.4 |
| type III secretion system translocon subunit YopD |
| YP_RS21265 | 1.5 |
| type III secretion system translocon subunit YopB |
| YP_RS21260 | 1.7 |
| type III secretion system chaperone LcrH |
| YP_RS21255 | 1.8 |
| type III secretion system protein LcrV |
| YP_RS21250 | 1.8 |
| type III secretion protein LcrG |
| YP_RS21245 | 1 |
| type III secretion system regulator LcrR |
| YP_RS21235 | 1.9 |
| type III secretion system chaperone YscY |
| YP_RS21230 | 1.9 |
| type III secretion system protein YscX |
| YP_RS21225 | 1.5 |
| type III secretion chaperone SycN |
| YP_RS21220 | 1.2 |
| type III secretion system gatekeeper subunit TyeA |
| YP_RS21215 | 1.2 |
| type III secretion system gatekeeper subunit YopN |
| YP_RS21190 | 1.1 |
| type III secretion system export apparatus protein SctR |
| YP_RS21160 | 2.5 |
| type III secretion system protein YscA |
| YP_RS21155 | 1.8 |
| type III secretion system chaperone YscB |
| YP_RS21145 | 1.3 |
| type III secretion system inner membrane ring subunit SctD |
| YP_RS21140 | 1.2 |
| YscE family type III secretion system needle protein co-chaperone |
| YP_RS21135 | 1.3 |
| type III secretion system needle filament subunit SctF |
| YP_RS21130 | 1.2 |
| YscG family type III secretion protein |
| YP_RS21110 | 1.5 |
| type III secretion system sorting platform protein YscK |
| YP_RS21080 | 1.1 |
| T3SS effector protein-tyrosine-phosphatase YopH |
| YP_RS21065 | 1.4 |
| type III secretion system effector acetyltransferase YopJ |
| YP_RS21060 | 1 |
| T3SS effector protein kinase YopO/YpkA |